Skip to main content

Table 1 Sample demographics for case-control series

From: ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease

Series

n (%)

Mean AAD ± SD (Years)

Females (%)

ϵ4+ Subjects (%)

AD

CON

AD

CON

AD

CON

AD

CON

Jacksonville

1020

(41.2)

1453

(58.8)

77.7

(6.46)

79.5

(7.86)

623

(61.1)

838

(57.7)

653

(64.0)

338

(23.3)

Rochester

600

(19.9)

2409

(80.1)

80

(7.72)

78.3

(5.56)

363

(60.5)

1294

(53.7)

328

(54.7)

571

(23.7)

Poland

250

(100)

0

(0)

74.4

(5.19)

NA

(NA)

156

(62.4)

NA

(NA)

139

(55.6)

NA

(NA)

Norway

345

(38.5)

552

(61.5)

80.2

(7.25)

75.4

(6.73)

241

(69.9)

330

(59.8)

217

(62.9)

132

(23.9)

NCRAD

702

(77.1)

209

(22.9)

75.2

(6.76)

78.3

(8.88)

455

(64.8)

129

(61.7)

551

(78.5)

34

(16.3)

Autopsy*

1211

(76.9)

363

(23.1)

81.4

(8.56)

75.9

(8.14)

695

(57.4)

155

(42.7)

744

(61.4)

98

(27.0)

Total

4128

(45.3)

4986

(54.7)

78.7

(7.76)

78.2

(6.91)

2533

(61.4)

2746

(55.1)

2632

(63.8)

1155

(23.2)

  1. *Autopsy controls unlike the clinical controls, who were neurologically normal, include some non-AD degenerative disorders.